Dutch health-tech startup Lapsi Health raises USD 3.7M in oversubscribed Seed Round to continue their development and enter the US market
Summary
AMSTERDAM, Jan. 10, 2023 /PRNewswire/ -- Dutch healthtech startup is developing sound-based medical technology (and software tools) to empower clinicians at the point of care and to enhance remote consultations. The company last raised in the beginning of last year, netting a 700K Pre-Seed Round in March 2022 and won the Eurostars 1M grant for the development of their deep tech.Today its announcing an oversubscribed sequel: The Seed Series clocks in at $3.7M and will be used to continue their technology development, to acquire FDA certification and to begin commercialization activities in the USA.Investors in this latest round for the 2022-founded startup are a mix of old and new backers: The Seed Series is led by Sahir Ali of , a Texas-based family office that has recently stepped into the Venture Capital world with investments in the space of Artificial intelligence and Tech Bio. In the last quarter of 2022, the company welcomed a new member of the Advisory Board, Junaid Bajwa, MD,Chief Medical Scientist at Microsoft. The technology will improve patient experience and outcomes while supporting the new normal for healthcare and clinical research," said Advisory Board Member and co-Chair of the DTRA, Craig Lipset. said Chief Medical Officer and co-Founder Diana van Stijn a leading expert in digital therapeutics and paediatrics.The founding team of Lapsi Health also includes: Seamus Holohan, COO and Rodrigo Alvez, CTO.About Lapsi Health: In the last 10 months, the company has grown from 4 to more than 10 employees (including their Head of Engineering, Toni Leinonen, founder of Haltian and former lead within the ) and 8 advisors.
Funding
Review available funding amount, funding date, investors, and linked company information related to Dutch health-tech startup Lapsi Health raises USD 3.7M in oversubscribed Seed Round to continue their development and enter the US market in the interactive ISVWorld profile.